Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

Published 2018 View Full Article

Authors

Keywords

Journal

LANCET

Volume 391, Issue 10122, Pages 748-757

Publisher

Elsevier BV

Online

2017-12-19

DOI

10.1016/s0140-6736(17)33297-x

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

LANCET

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Add your recorded webinar

Become a Peeref-certified reviewer